These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1313345)

  • 1. The urge to prevent restenosis after percutaneous transluminal coronary angioplasty. Scylla and Charybdis in disguise.
    Becker AE
    Circulation; 1992 Apr; 85(4):1632-3. PubMed ID: 1313345
    [No Abstract]   [Full Text] [Related]  

  • 2. The paradigm of restenosis following percutaneous transluminal coronary angioplasty.
    Preisack MB; Karsch KR
    Eur Heart J; 1993 Nov; 14 Suppl I():187-92. PubMed ID: 8293774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study.
    Cairns JA; Gill J; Morton B; Roberts R; Gent M; Hirsh J; Holder D; Finnie K; Marquis JF; Naqvi S; Cohen E
    Circulation; 1996 Oct; 94(7):1553-60. PubMed ID: 8840843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight heparin in prevention of restenosis after PTCA.
    Preisack MB; Karsch KR
    Thromb Res; 1996; 81(2 Suppl):S53-9. PubMed ID: 8822128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of subcutaneous low molecular weight heparin (ardeparin) for reduction of restenosis after percutaneous transluminal coronary angioplasty.
    Gimple LW; Herrmann HC; Winniford M; Mammen E
    Am J Cardiol; 1999 Jun; 83(11):1524-9. PubMed ID: 10363865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fraxiparin for prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Amann FW; Neuenschwander C; Meyer BJ
    Semin Thromb Hemost; 1993; 19 Suppl 1():160-3. PubMed ID: 8395720
    [No Abstract]   [Full Text] [Related]  

  • 7. Restenosis after coronary angioplasty.
    Hamon M; Bauters C; McFadden EP; Wernert N; Lablanche JM; Dupuis B; Bertrand ME
    Eur Heart J; 1995 Aug; 16 Suppl I():33-48. PubMed ID: 8829956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental and early clinical experience with reviparin-sodium for prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Preisack MB; Karsch KR
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S55-8; discussion S59-60. PubMed ID: 8180331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Southwestern internal medicine conference: restenosis: the Achilles heel of coronary angioplasty.
    Lange RA; Willard JE; Hillis LD
    Am J Med Sci; 1993 Oct; 306(4):265-75. PubMed ID: 8213896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cellular proliferation after experimental balloon angioplasty by low-molecular-weight heparin.
    Hanke H; Oberhoff M; Hanke S; Hassenstein S; Kamenz J; Schmid KM; Betz E; Karsch KR
    Circulation; 1992 Apr; 85(4):1548-56. PubMed ID: 1313343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic roles of heparin and glucocorticoids to prevent restenosis after coronary angioplasty.
    Berk BC; Gordon JB; Alexander RW
    J Am Coll Cardiol; 1991 May; 17(6 Suppl B):111B-117B. PubMed ID: 2016469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous transluminal coronary angioplasty restenosis: potential prevention with laser balloon angioplasty.
    Spears JR
    Am J Cardiol; 1987 Jul; 60(3):61B-64B. PubMed ID: 2956846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of recombinant hirudin (CGP 39,393/TMREVASC) in the prevention of restenosis after percutaneous transluminal coronary angioplasty. Rationale and design of the HELVETICA trial, a multicentre randomized double blind heparin controlled study.
    Herrman JP; Simon R; Umans VA; Peerboom PF; Keane D; Rijnierse JJ; Bach D; Kobi P; Kerry R; Close P
    Eur Heart J; 1995 Nov; 16 Suppl L():56-62. PubMed ID: 8869020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cilostazol in preventing restenosis after percutaneous transluminal coronary angioplasty.
    Take S; Matsutani M; Ueda H; Hamaguchi H; Konishi H; Baba Y; Kawaratani H; Sugiura T; Iwasaka T; Inada M
    Am J Cardiol; 1997 Apr; 79(8):1097-9. PubMed ID: 9114771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Circulation; 1992 Jul; 86(1):100-10. PubMed ID: 1535568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
    Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
    Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanisms of coronary restenosis: insights from experimental models.
    Ferns GA; Avades TY
    Int J Exp Pathol; 2000 Apr; 81(2):63-88. PubMed ID: 10762439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot findings of a percutaneous transluminal coronary angioplasty-restenosis-prone prevention program.
    Goodman M
    Mayo Clin Proc; 1997 May; 72(5):487. PubMed ID: 9146696
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials of restenosis after coronary angioplasty.
    Popma JJ; Califf RM; Topol EJ
    Circulation; 1991 Sep; 84(3):1426-36. PubMed ID: 1884465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.